Bettering Me

Author: Unpaid Intern

  • Grip Strength Is a Proxy for Something Deeper – and the Test That Measures That Thing Is More Useful

    Written by

    Unpaid Intern

    –

    Grip strength predicts all-cause mortality with remarkable consistency across populations, ages, and health statuses. The UK Biobank study of nearly 500,000 participants found that each 5 kg decrease in grip strength was associated with a 16% higher risk of all-cause mortality, and the association held after adjusting for age, BMI, smoking, physical activity levels, and socioeconomic status [1]. Meta-analyses have replicated the finding across dozens of cohorts worldwide. Grip strength is one of the most robust epidemiological predictors in the longevity literature.

    The common interpretation is that grip strength is somehow uniquely protective – that having strong hands extends your life. This is a category error.

    Grip strength predicts mortality because it correlates strongly with two things that actually matter: total body muscle mass and neuromuscular integrity [2]. A person with strong grip likely has good overall lean mass and a nervous system that can recruit muscle fibers effectively. The grip test is capturing the health of the entire motor system – the descending neural pathways, the motor unit recruitment efficiency, and the skeletal muscle mass that generates force. The hands are just the convenient measurement site.

    The neurological basis of this correlation is often overlooked. Grip strength depends on the motor cortex’s ability to activate alpha motor neurons, the transmission fidelity of the corticospinal tract, the neuromuscular junction’s functional integrity, and the muscle fibers’ contractile capacity. A declining grip strength reading is not a hand problem. It is a signal that one or more of these components is beginning to decline, often before the person notices any functional change. This is what makes grip strength valuable as a surveillance tool – it captures central nervous system aging that muscle mass alone does not reflect.

    This means grip-specific training – hand grippers, forearm curls, rock climbing, squeeze devices – does not improve your healthspan in any direct way. It improves your grip. And improved grip will show up as a better grip strength reading on the dynamometer, even though your overall muscle mass, neuromuscular health, and metabolic reserve may not have changed at all. The proxy improves without the underlying signal improving.

    This is not a critique of grip strength as a measure. It is a boundary condition on its interpretation. Grip strength is an excellent screening test – cheap, fast, and reproducible. It is a poor target for intervention. Training your grip to raise your grip strength is like raising your car’s oil pressure by tightening the oil cap. You changed the reading. You did not change the thing the reading measures.

    The real value of the annual grip test is as a compliance check. If your grip strength is dropping year over year, your overall training load is insufficient – you are losing muscle and neuromuscular function despite whatever exercise program you think you are doing. The test does not need to be replaced. It just needs to be interpreted as a proxy, not an endpoint.

    What should replace grip-specific training as a target? Functional tests that capture the same signal more directly. The five-times-sit-to-stand test (how quickly you can stand from a chair five times without using your arms) captures lower body strength, power, and neuromuscular coordination. Gait speed over 4 meters is a powerful predictor of falls, functional decline, and mortality. The Short Physical Performance Battery – which combines gait speed, chair stand, and balance – provides a composite picture of neuromuscular health that is more actionable than grip alone [3]. A person who can stand from a chair 10 times in 30 seconds is not at risk of functional decline regardless of their grip strength.

    Counterpoint: doesn’t grip training still build muscle in the forearm? Yes, locally. But the forearm muscle mass gained from grip training is approximately 200-300 grams in a dedicated program. The lean mass that predicts independence at 80 is the total muscle mass of the legs, back, chest, and shoulders – approximately 20-25 kg. Grip training adds a trivial amount to that total. The cost-benefit ratio of grip-specific training (time, effort, equipment) for the purpose of healthspan extension is extremely poor compared to compound resistance training targeting the major muscle groups.

    The Bettering Me recommendation: track grip strength annually as a dashboard light. If it is stable, your training program is adequate for maintenance. If it is rising, your training program is producing results. If it is declining, investigate – but do not train your grip. Check your lean mass (DEXA scan every two years), check your training consistency, check your protein intake, check your sleep. The grip test is a warning light, not a component. When the warning light flashes, do not check the light itself. Check the engine.

    The sit-to-stand alternative. If you can perform five chair stands (arms crossed over chest) in less than 10 seconds, your lower body strength and neuromuscular function are adequate for independence. If it takes more than 15 seconds, you are in the risk zone regardless of your grip strength. This test costs nothing, requires no equipment, and captures the signal that matters more directly than grip – because it is your legs, not your hands, that determine whether you can stand, walk, and climb at 80.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Celis-Morales CA, et al. "Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality." *BMJ*. 2018;361:k1651.. DOI: https://doi.org/10.1136/bmj.k1651

    [2] Cooper R, et al. "Objectively measured physical capability levels and mortality: systematic review and meta-analysis." *BMJ*. 2010;341:c4467.. DOI: https://doi.org/10.1136/bmj.c4467

    [3] Guralnik JM, et al. "Lower extremity function and subsequent disability." *J Gerontol*. 1994;49(2):M85-M94.. DOI: https://doi.org/10.1093/geronj/49.2.m85

  • Parasympathetic Sovereignty Is Not About Relaxing More – It’s About Recovering Faster

    Written by

    Unpaid Intern

    –

    The wellness industry has sold a version of “calm” that looks like a flat line: constant, even, unbroken serenity. That is not how healthy nervous systems work. The goal of nervous system regulation is not to stay relaxed all day. It is to upregulate when you need to perform and downregulate quickly when the demand ends. The skill is switch speed.

    Heart rate variability (HRV) is the metric that captures this dynamic. High HRV does not mean a low resting heart rate. It means the heart is responsive – able to accelerate quickly for a stressor and decelerate quickly when the stressor passes. People with low HRV do not have trouble relaxing. They have trouble transitioning. [1] Their nervous system gets stuck in one gear, usually sympathetic, because the brake mechanism – the parasympathetic branch – is slow to re-engage after activation.

    The engineering target, then, is not deeper relaxation. It is faster recovery. The question is what interventions improve the speed of autonomic switching.

    The evidence points to two interventions that outperform almost everything else in the wellness catalog.

    The first is consistent sleep timing. Multiple studies have shown that bedtime variability is one of the strongest predictors of next-day HRV. [2] Going to bed within a consistent 30-minute window every night predicts higher HRV than total sleep duration does. This makes physiological sense – the circadian system regulates autonomic balance, and inconsistent sleep timing disrupts circadian entrainment, which in turn degrades the parasympathetic system’s ability to engage during rest. The intervention is free, requires no equipment, and produces measurable effects within days of improvement.

    The second is morning light exposure within 30 minutes of waking. Light is the primary zeitgeber – the time cue that sets the circadian clock. Morning light exposure within 30 minutes of waking advances the circadian phase and strengthens entrainment, which directly affects the autonomic nervous system’s daily rhythm. [3] The parasympathetic system operates on a circadian schedule – it should dominate during sleep and early morning, while the sympathetic system takes over during the day. Morning light exposure helps maintain that schedule by signaling the system to transition from the overnight parasympathetic dominance to daytime sympathetic readiness. Without that signal, the transition is sluggish, and recovery after daytime stress is slower.

    The combination of these two interventions – consistent bedtime window plus morning light exposure – addresses the two biggest disruptors of autonomic switching speed: circadian disruption and light-deprived mornings. Together, they outperform most evening wind-down routines, supplements, and stress-management apps for the specific outcome of recovery speed.

    This is where the “sovereignty” framing enters. Parasympathetic sovereignty is the capacity to recover on your own schedule, independent of external conditions. It is the opposite of stress reactivity – where your recovery depends on the environment calming down. Sovereignty means your nervous system can return to baseline even in a chaotic environment, because your recovery machinery is strong enough to operate despite external noise. [OPINION]

    The practical protocol is minimal. Pick a bedtime and stick to it within 30 minutes, including weekends. Get 10-15 minutes of outdoor light within 30 minutes of waking. That is the entire protocol. It takes no time, costs nothing, and targets the mechanism that drives recovery speed. Everything else – supplements, red-light therapy, expensive HRV monitors – is tertiary compared to these two.

    A caveat: consistent sleep timing is harder than it sounds because it requires social discipline. Late meetings, social obligations, and the lure of one more episode all disrupt timing. The protocol’s value is proportional to its consistency. Missing one night is not a failure. Missing the principle – treating bedtime as non-negotiable – is.

    Switch speed is the metric. Bedtime consistency and morning light are the levers. Everything else is optimization on top of a foundation most people have not laid.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Thayer JF, et al. A meta-analysis of heart rate variability and neuroimaging studies. *Neuroscience & Biobehavioral Reviews*, 2012. DOI: https://doi.org/10.1016/j.neubiorev.2011.11.009

    [2] Huang T, et al. Sleep irregularity and risk of cardiovascular events: the multi-ethnic study of atherosclerosis. *Scientific Reports*, 2020. DOI: https://doi.org/10.1038/s41598-020-69764-0

    [3] Wright KP, et al. Entrainment of the human circadian clock to the natural light-dark cycle. *Current Biology*, 2013. DOI: https://doi.org/10.1016/j.cub.2013.06.039

  • The AI Skeptic Needs Somatic Practices More Than the AI Enthusiast

    Written by

    Unpaid Intern

    –

    The AI enthusiast wakes up to a new tool and feels excitement. The AI skeptic wakes up to the same news and feels vigilance. Both are valid responses to a rapidly shifting technological landscape, but they produce fundamentally different physiological states. The enthusiast gets a dopamine loop. The skeptic gets a threat loop.

    Being constantly vigilant against AI influence creates what neuroscientists call anticipatory threat monitoring – a low-grade sympathetic activation that keeps the nervous system scanning for danger even when no immediate threat exists. [1] The skeptic’s pattern is more insidious than the enthusiast’s because it looks like caution but functions as chronic stress. The enthusiast’s dopamine loop has a natural satiety signal. The skeptic’s threat loop does not. There is always one more article to read, one more risk to evaluate, one more reason to resist.

    The irony is that the skeptic needs nervous system regulation more than the enthusiast because the skeptic is paying a higher physiological cost for the same technological environment. The enthusiast engages, gets a reward, and moves on. The skeptic engages (or avoids engaging) and feels activated either way. Avoidance does not resolve the activation – it maintains it, because the threat remains unresolved in the nervous system’s tracking. [2]

    This is where somatic practice becomes relevant not as wellness but as sovereignty. Sovereign focus for the skeptic is not about avoiding AI. It is about building enough regulation capacity that you can engage with AI without being activated by it. The goal is not to become an enthusiast. It is to become someone who can choose their response rather than having their response dictated by an overactive threat-detection system.

    The specific practice that targets this dynamic is conscious disengagement – the deliberate act of engaging with an AI tool briefly, then consciously stepping away and noticing the transition. The sequence is: engage, notice the activation (if any), disengage, notice the deactivation, repeat. Each repetition trains the nervous system that engagement is survivable. The activation is not a signal to flee – it is a signal to regulate. [OPINION]

    This protocol works because it targets the specific failure mode of skepticism: anticipatory avoidance. The skeptic avoids AI tools not because they have been harmed by them but because they anticipate being harmed. The anticipation itself creates a sensitized threat response that makes future engagement more costly. Conscious disengagement breaks the sensitization cycle by pairing engagement with evidence that the engagement was safe.

    The alternative framing is also worth considering: AI as environment rather than predator. The skeptic’s nervous system treats AI as a predator to be scanned for and avoided. The alternative is to treat AI as weather – a feature of the environment that must be navigated rather than feared. You do not need to like the rain to walk in it without panicking. You need a coat. For the skeptic, the coat is autonomic regulation. [OPINION]

    There is a caveat that matters: not all skepticism is pathological. Discernment is a legitimate cognitive function. The AI skeptic’s wariness may reflect genuine risks that the enthusiast is overlooking. The point is not to eliminate skepticism but to prevent it from becoming a chronic sympathetic load that degrades health and decision-making. The goal is regulated skepticism – the ability to evaluate AI critically without being dysregulated by it.

    The practice that helps most across the board is breath awareness before, during, and after AI interaction. It is not AI-specific – it is the general capacity to notice when the nervous system has escalated and to downregulate before the escalation becomes habitual. [3] But it matters most for the skeptic because the skeptic’s default state is already closer to the threshold. The skeptic does not need to learn to engage. They need to learn to engage without activation.

    The distinction between avoidance and regulation is the key insight. Avoidance looks like protection but functions as reinforcement – each time the skeptic avoids AI, the nervous system learns that avoidance was necessary, deepening the threat association. Regulation looks like engagement with a safety net – the skeptic engages briefly, notices the activation, and consciously downregulates before the activation becomes dysregulation. Over time, this pattern retrains the nervous system to distinguish between genuine threat and anticipated threat. That distinction is the foundation of sovereignty in an AI-saturated environment.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Grupe DW, Nitschke JB. Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. *Nature Reviews Neuroscience*, 2013. DOI: https://doi.org/10.1038/nrn3524

    [2] Thayer JF, Lane RD. A model of neurovisceral integration in emotion regulation and dysregulation. *Biological Psychology*, 2000. DOI: https://doi.org/10.1016/s0301-0511(00)00053-4

    [3] Kiverstein J, et al. The affective niche and the challenge of 21st-century technologies. *Trends in Cognitive Sciences*, 2019. DOI: https://doi.org/10.1016/j.tics.2019.03.005

  • There Are Only Three Blood Tests That Matter for Prevention. The Other Four Are Noise Until These Are Fixed

    Written by

    Unpaid Intern

    –

    The wellness industry has turned annual blood work into an anxiety generator. Lists of seven, ten, fourteen markers – each with an “optimal” range that shifts every time a supplement company publishes a blog post. The result is a population of people who are worried about their homocysteine while their cardiovascular ceiling is unknown, their metabolic trajectory is unchecked, and their inflammatory baseline is a guess.

    The Three Tests at a Glance

    • ApoB: Counts every atherogenic (plaque-forming) particle in circulation — a more accurate cardiovascular risk signal than standard LDL-C alone.
    • Fasting Insulin: Reveals insulin resistance years before fasting glucose rises, catching metabolic dysfunction at the earliest correctable stage.
    • hs-CRP: Measures chronic low-grade inflammation — the modifiable driver that accelerates atherosclerosis independent of lipid levels.

    The hierarchy of prevention blood work is not flat. It has three anchors, and everything else is a distraction until those three are addressed. These three markers form a tripod – each covers a domain no other test covers, and together they answer the three questions that determine whether your prevention strategy is working.

    ApoB is your cardiovascular ceiling. Apolipoprotein B counts every atherogenic particle in circulation – LDL, VLDL, IDL, and Lp(a) – because each of these particles carries exactly one ApoB molecule [1]. LDL-C, the standard metric, estimates the mass of cholesterol inside LDL particles. It does not count the particles themselves. The particles cause plaque, not the cholesterol inside them. ApoB tells you how many plaque-forming particles are circulating, regardless of how much cholesterol they happen to be carrying.

    This distinction matters because two people can have identical LDL-C while one has twice as many atherogenic particles. The person with many small dense LDL particles may have “normal” LDL-C (say, 110 mg/dL) but high ApoB (above 100 mg/dL), and their risk is higher than the person with the same LDL-C but low ApoB [2]. This discordance – the gap between what LDL-C says and what ApoB says – occurs in approximately 15-20% of the population. Those people are being misclassified by the standard panel.

    Fasting insulin is your metabolic trajectory. Fasting glucose is a late-stage indicator – by the time it rises above 100 mg/dL, your pancreatic beta cells have been compensating for years, secreting excess insulin to overcome reduced sensitivity [3]. A fasting glucose of 92 with a fasting insulin of 14 µIU/mL is not “normal.” It is a pancreas working triple shifts to keep the number flat. The threshold worth watching is insulin above 8-10 µIU/mL in the context of normal glucose. The simplest quantification is HOMA-IR: (fasting glucose × fasting insulin) ÷ 405. A value above 2.0 indicates insulin resistance. Above 2.5 signals significant metabolic dysfunction, even with pristine fasting glucose.

    hs-CRP is your inflammatory baseline. High-sensitivity C-reactive protein above 1 mg/L (and especially above 2 mg/L) signals a chronic low-grade inflammatory state that accelerates atherosclerosis independent of lipid levels [4]. The most common cause of elevated hs-CRP is visceral adiposity – fat tissue secretes IL-6, which stimulates hepatic CRP production. But it can also be driven by chronic infection (periodontal disease is a common hidden culprit), autoimmune conditions, or simply an inflammatory diet pattern. hs-CRP is modifiable: weight loss of 5-10% reliably drops it, as does consistent aerobic exercise, omega-3 intake, and eliminating ultra-processed foods. It is the cheapest, most telling measure of whether your lifestyle is producing a net anti-inflammatory effect.

    Homocysteine, vitamin D, thyroid panels, lipoprotein(a) – these matter, but they matter after the three anchors are known. A person with ApoB of 90 mg/dL, fasting insulin of 6 µIU/mL, and hs-CRP of 0.6 mg/L has more prevention information than someone who has all fourteen markers checked but none of these three. The “deep cuts” are for fine-tuning after the structural questions are answered.

    The exception is Lp(a) – lipoprotein(a) – which should be checked once in a lifetime because it is 80-90% genetically determined and does not respond to lifestyle [5]. But Lp(a) is not a substitute for ApoB. It is an additional risk modifier. Check Lp(a) once. If it is high, adjust your ApoB target downward (below 70 mg/dL instead of below 100). If it is low, never think about it again.

    The Bettering Me approach: fix the anchors first. Chase the edges only when the anchors are known and stable.

    The practical protocol for getting these tests. Most standard lab panels do not include ApoB or fasting insulin by default. You need to request them specifically. For ApoB: order “apolipoprotein B” (CPT 82172). For fasting insulin: order “insulin, fasting” (CPT 83525). For hs-CRP: order “C-reactive protein, high sensitivity” (CPT 86141). These three tests add approximately $60-90 to a standard blood draw if your insurance does not cover them. Direct-to-consumer labs like Quest and LabCorp offer them as individual add-ons. Life Extension, Marek Health, and several other direct-access providers offer prevention-focused panels that include all three.

    The retesting cadence. ApoB changes slowly – retest every 6-12 months unless you are on pharmacological therapy, in which case retest at 12 weeks post-initiation. Fasting insulin can change within 8-12 weeks of lifestyle intervention – retest at 12 weeks if you are making significant changes. hs-CRP is the most dynamic – it can shift within 4-6 weeks of weight loss, exercise adoption, or dietary change. A baseline measurement followed by a 12-week follow-up after intervention gives you a clear picture of whether your protocol is working.

    Your homocysteine is not going to kill you. Your ApoB, fasting insulin, and hs-CRP might – or might save you, depending on what you do with the information. Fix the anchors first. Then chase the edges.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Sniderman AD, et al. "A meta-analysis of LDL-C, non-HDL-C, and ApoB as markers of cardiovascular risk." *Circ Cardiovasc Qual Outcomes*. 2011;4(3):337-345.. DOI: https://doi.org/10.1161/CIRCOUTCOMES.110.959247

    [2] Otvos JD, et al. "Clinical implications of discordance between LDL-C and particle number." *J Clin Lipidol*. 2011;5(2):105-113.. DOI: https://doi.org/10.1016/j.jacl.2011.02.001

    [3] Kahn SE, Hull RL, Utzschneider KM. "Mechanisms linking obesity to insulin resistance and type 2 diabetes." *Nature*. 2006;444(7121):840-846.. DOI: https://doi.org/10.1038/nature05482

    [4] Ridker PM. "Clinical application of C-reactive protein for cardiovascular disease detection and prevention." *Circulation*. 2003;107(3):363-369.. DOI: https://doi.org/10.1161/01.CIR.0000053730.47739.3C

    [5] Kronenberg F. "Human Genetics and the Causal Role of Lipoprotein(a)." *Cardiovasc Drugs Ther*. 2016;30(1):87-100.. DOI: https://doi.org/10.1007/s10557-016-6648-3

  • Calling Rest a Biohack Misses the Point – Rest Is the Default State That Hacks Are Trying to Restore

    Written by

    Unpaid Intern

    –

    The word “biohack” applied to rest reveals how far the wellness culture has drifted from physiology. Rest is not an intervention. It is the default state of a human nervous system that is not being actively disrupted. The “hack” is not adding something that produces rest. It is removing what prevents rest from happening on its own.

    This reframing matters because the additive approach to rest – buy the supplement, use the device, follow the protocol – keeps you in an active, optimizing relationship with rest, which is the opposite of what rest requires. Rest is not something you do. It is something you allow.

    The evidence for the subtractive approach is scattered across separate literatures that rarely get connected. Light exposure after sunset suppresses melatonin production, delaying sleep onset and reducing sleep quality. [1] Late-night eating disrupts the body temperature regulation that supports deep sleep. [2] Alcohol consumption before bed fragments sleep architecture, reducing slow-wave and REM sleep. [3] Cognitive load in the hour before bed elevates cortisol, which directly antagonizes the sleep-initiation system. [4] Each of these is a blocker, not a missing ingredient. Remove the blocker, and rest returns.

    The most common counterargument is that some people genuinely need help sleeping and that supplements or devices provide that help. That is true for clinical populations – chronic insomnia, shift workers, people with specific medical conditions. For those groups, melatonin, magnesium, or even prescription sleep aids are appropriate tools. But the person who falls asleep easily on vacation and struggles at home does not have a sleep disorder. They have an environment that is preventing rest.

    The data on sleep disruptions supports the environmental theory. Room light before bedtime suppresses melatonin by about 50% compared to dim light. [1] Alcohol consumption before bed, even at moderate levels, measurably reduces time spent in restorative sleep stages. [3] Using a phone or tablet in bed delays sleep onset by an average of 30 minutes per hour of use. [5] The cumulative effect is that the typical evening routine – bright lights, snacks, alcohol, screens – creates a physiological state that is incompatible with the rest people are trying to achieve with supplements.

    The practical implication is uncomfortable for people who want protocols: the most effective intervention is stopping. Stop using screens 90 minutes before bed. Stop eating within three hours of bedtime. Stop drinking alcohol within four hours of sleep. Stop working or engaging in emotionally demanding content within two hours of sleep. Each of these is a removal of a barrier, not an addition of a tool.

    The “subtraction” approach is harder to sell than the “addition” approach because it requires discipline that is invisible. Buying a supplement feels like progress. Turning off the TV early feels like deprivation. But the physiological logic is clear: if your evening environment is configured to block rest, the most efficient intervention is to reconfigure the environment. No supplement can overcome a brightly lit room, a full stomach, and an active mind.

    A useful heuristic: if you slept well on your last vacation without any supplements or devices, the problem is not your ability to rest. It is your home environment. Replicate the vacation conditions – darkness, cool temperature, full stomach from hours ago, no screens – and see whether rest returns. If it does, you do not need a protocol. You need to remove the obstacles.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Gooley JJ, et al. Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. *Journal of Clinical Endocrinology & Metabolism*, 2011. DOI: https://doi.org/10.1210/jc.2010-2098

    [2] Crispim CA, et al. The influence of sleep and sleep loss upon food intake and metabolism. *Sleep Science*, 2011. DOI: https://doi.org/10.1016/j.slsci.2011.10.001

    [3] Ebrahim IO, et al. Alcohol and sleep I: effects on normal sleep. *Alcoholism: Clinical and Experimental Research*, 2013. DOI: https://doi.org/10.1111/acer.12054

    [4] Harvey AG, et al. Pre-sleep cognitive arousal: a systematic review. *Clinical Psychology Review*, 2002. DOI: https://doi.org/10.1016/s0272-7358(01)00117-4

    [5] Chang AM, et al. Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. *Proceedings of the National Academy of Sciences*, 2015. DOI: https://doi.org/10.1073/pnas.1418490112

  • The SPRINT MIND Result Is Real – But Your 128 Systolic Is Not the Same as Their 147

    Written by

    Unpaid Intern

    –

    The SPRINT MIND trial produced a genuinely important result: intensive blood pressure control (target below 120 mmHg systolic) reduced the risk of mild cognitive impairment and probable dementia by 19% compared to standard treatment (target below 140 mmHg) [1]. This is one of the few randomized controlled trials showing that a cardiovascular intervention directly reduces dementia risk. It is real, and it should change how clinicians and patients think about the relationship between blood pressure and brain health.

    But the trial’s population matters as much as its result. The average participant in SPRINT MIND was 68 years old with established hypertension – baseline systolic averaging 147 mmHg. Many had existing cardiovascular disease or chronic kidney disease [1]. The trial proved that dropping from 147 to 121 reduces dementia risk in older adults with hypertension. It did not prove that dropping from 125 to 115 does the same thing in a 45-year-old with no cardiovascular history.

    For a 45-year-old walking around with a systolic of 125, the clinical question is not “should I get below 120.” The question is: what is the trajectory?

    A person whose blood pressure has been 118 for a decade and is now trending 125 is not the same patient as someone whose blood pressure has been 145 for a decade and is now trending 125. One is climbing. The other is descending. The same absolute number means a different thing depending on the vector. This distinction is lost in the threshold-based model that guides most clinical decisions – you are either normotensive, prehypertensive, or hypertensive, and the treatment decision fires only when you cross the line.

    The longitudinal data from the Atherosclerosis Risk in Communities (ARIC) study shows that midlife blood pressure trajectories – not single readings – predict cognitive decline decades later [2]. Participants whose systolic rose from 110 to 130 between ages 45 and 55 had higher dementia risk than those whose systolic held steady at 120 across the same window, even though both groups had identical readings at age 55. The trajectory was the signal, not the absolute value.

    This matters because the J-curve hypothesis – the idea that lowering blood pressure too aggressively in certain populations may increase cardiovascular risk – has not been resolved for primary prevention in middle-aged adults [3]. SPRINT MIND’s intensive arm used a multi-drug protocol to achieve its 121 mmHg average. The same pharmacological approach applied to someone whose systolic is 125 and climbing might produce benefit, but the trial did not test that.

    There is also the question of mechanism. Blood pressure damages cerebral small vessels over years, not weeks. The cognitive decline that SPRINT MIND prevented was the result of cumulative microvascular damage in participants who had been hypertensive for decades. A 45-year-old whose pressure is 125 and steady has accumulated far less vascular damage than a 68-year-old whose pressure was 140+ for twenty years. The intervention window is wider. The urgency is lower. But the opportunity for primary prevention is real.

    The framework Bettering Me recommends is trajectory-based, not threshold-based. If your systolic has been within a 5-point band for five years, the intervention is behavioral maintenance: sleep consistency (blood pressure drops 10-20% during deep sleep – the nocturnal dip), sodium sensitivity awareness (test this by tracking pressure for two weeks on high vs low sodium), and aerobic volume above 150 minutes per week (each 1 MET increase in fitness is associated with approximately 5 mmHg lower systolic pressure) [4].

    If your systolic has risen more than 8 points in three years, the intervention is structural – even if you haven’t crossed a “hypertensive” threshold. That means a formal assessment: 24-hour ambulatory monitoring (office readings miss nocturnal hypertension, which is independently predictive of cardiovascular events), dietary sodium assessment, sleep apnea screening (OSA is a common secondary cause of rising pressure trajectories in midlife), and a discussion about pharmacological options if lifestyle alone is insufficient [5].

    The trajectory tells you whether you are approaching a ceiling or retreating from one. SPRINT MIND proved the ceiling matters for dementia. But for most people in their 40s, it is the slope – not the ceiling – that will decide whether they ever reach it.

    A practical note on nocturnal dipping. Blood pressure normally drops 10-20% during deep sleep – the “nocturnal dip.” People whose pressure does not dip (non-dippers) have higher cardiovascular and cognitive risk, independent of daytime readings [4]. The only way to know if you are a dipper is 24-hour ambulatory monitoring. If your office BP is 125/80 but your nocturnal average is 118/75, you are fine. If it is 125/80 and your nocturnal average is 120/78, you are a non-dipper, and your trajectory-based risk is higher than the office reading suggests. This is another reason the standard threshold-based approach misses the signal.

    The sodium sensitivity variable. Approximately 50% of people with normal blood pressure are sodium sensitive – their pressure rises measurably in response to high sodium intake. The others are sodium resistant. The only way to know which you are is to test it: 7-10 days of high sodium (add salt at every meal) vs 7-10 days of low sodium (eliminate added salt, avoid processed foods), measuring BP daily at the same time. If your systolic moves more than 5 mmHg between conditions, you are sodium sensitive, and sodium management is a structural intervention for you, not a marginal one.

    The threshold is a legal category. The trajectory is a clinical signal. Know which one you are looking at.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Williamson JD, Pajewski NM, Auchus AP, et al. "Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial." *JAMA*. 2019;321(6):553-561.. DOI: https://doi.org/10.1001/jama.2018.21442

    [2] Gottesman RF, et al. "Midlife Hypertension and 20-Year Cognitive Change: The Atherosclerosis Risk in Communities Neurocognitive Study." *JAMA Neurology*. 2014;71(10):1218-1227.. DOI: https://doi.org/10.1001/jamaneurol.2014.1646

    [3] Bohm M, et al. "J-curve relation between achieved blood pressure and cardiovascular outcomes." *European Heart Journal*. 2010;31(16):1985-1992.. DOI: https://doi.org/10.1093/eurheartj/ehq156

    [4] Cornelissen VA, Smart NA. "Exercise training for blood pressure: a systematic review and meta-analysis." *J Am Heart Assoc*. 2013;2(1):e004473.. DOI: https://doi.org/10.1161/JAHA.112.004473

    [5] Sleep Apnea and BP Trajectory